32 related articles for article (PubMed ID: 18305374)
1. Rare but impaired flavin-containing monooxygenase 3 (FMO3) variants reported in a recently updated Japanese mega-databank of genome resources.
Shimizu M; Makiguchi M; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
Drug Metab Pharmacokinet; 2024 Apr; 55():100539. PubMed ID: 38280279
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives.
Hisamuddin IM; Yang VW
Pharmacogenomics; 2007 Jun; 8(6):635-43. PubMed ID: 17559352
[TBL] [Abstract][Full Text] [Related]
3. Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug-Drug Interactions in Children.
Cleary Y; Kletzl H; Grimsey P; Heinig K; Ogungbenro K; Silber Baumann HE; Frey N; Aarons L; Galetin A; Gertz M
Clin Pharmacokinet; 2023 Jun; 62(6):891-904. PubMed ID: 37148485
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress-responsive transcription factor NRF2 is not indispensable for the human hepatic Flavin-containing monooxygenase-3 (FMO3) gene expression in HepG2 cells.
Rudraiah S; Gu X; Hines RN; Manautou JE
Toxicol In Vitro; 2016 Mar; 31():54-9. PubMed ID: 26616280
[TBL] [Abstract][Full Text] [Related]
5. Differential Fmo3 gene expression in various liver injury models involving hepatic oxidative stress in mice.
Rudraiah S; Moscovitz JE; Donepudi AC; Campion SN; Slitt AL; Aleksunes LM; Manautou JE
Toxicology; 2014 Nov; 325():85-95. PubMed ID: 25193093
[TBL] [Abstract][Full Text] [Related]
6. Developmental variations in metabolic capacity of flavin-containing mono-oxygenase 3 in childhood.
Shimizu M; Denton T; Kozono M; Cashman JR; Leeder JS; Yamazaki H
Br J Clin Pharmacol; 2011 Apr; 71(4):585-91. PubMed ID: 21395651
[TBL] [Abstract][Full Text] [Related]
7. Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation.
Cashman JR; Zhang J
Drug Metab Dispos; 2002 Oct; 30(10):1043-52. PubMed ID: 12228178
[TBL] [Abstract][Full Text] [Related]
8. [Individual differences of drug-metabolizing enzymes as determinants for the metabolic fate of chemicals--a study of trimethylamine and flavin-containing monooxygenase 3-].
Shimizu M
Yakugaku Zasshi; 2009 Nov; 129(11):1351-6. PubMed ID: 19881207
[TBL] [Abstract][Full Text] [Related]
9. Complex mechanism underlying transcriptional control of the haplotyped flavin-containing monooxygenase 3 (FMO3) gene in Japanese: different regulation between mutations in 5'-upstream distal region and common element in proximal region.
Shimizu M; Murayama N; Nagashima S; Fujieda M; Yamazaki H
Drug Metab Pharmacokinet; 2008; 23(1):54-8. PubMed ID: 18305374
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants.
Koukouritaki SB; Poch MT; Cabacungan ET; McCarver DG; Hines RN
Mol Pharmacol; 2005 Aug; 68(2):383-92. PubMed ID: 15858076
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
12. Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.
Shimizu M; Allerston CK; Shephard EA; Yamazaki H; Phillips IR
Br J Clin Pharmacol; 2014 May; 77(5):839-51. PubMed ID: 24028545
[TBL] [Abstract][Full Text] [Related]
13. Inter-individual variation in flavin-containing monooxygenase 3 in livers from Japanese: correlation with hepatic transcription factors.
Nagashima S; Shimizu M; Yano H; Murayama N; Kumai T; Kobayashi S; Guengerich FP; Yamazaki H
Drug Metab Pharmacokinet; 2009; 24(3):218-25. PubMed ID: 19571433
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
